Enzyme-linked Immunosorbent Assay (ELISA) Analyzers Market Share Driven by Diagnostic Advancements and Biopharma Research Expansion | Valuates Reports

Enzyme-linked Immunosorbent Assay (ELISA) Analyzers Market Size
The global market for Enzyme-linked Immunosorbent Assay (ELISA) Analyzers was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 827 million by 2031, growing at a CAGR of 2.5% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-0V7282/Global_Enzyme_linked_Immunosorbent_Assay_ELISA_Analyzers_Market_Insights_and_Forecast_to_2028

The Enzyme-linked Immunosorbent Assay (ELISA) Analyzers Market is experiencing notable market growth driven by the rising demand for precise, rapid, and automated immunoassay testing across healthcare and research sectors. Increasing prevalence of infectious and chronic diseases, coupled with advancements in diagnostic technology, has significantly influenced market trends. The market size continues to expand as laboratories and hospitals adopt automated ELISA analyzers to enhance accuracy, efficiency, and throughput in biomarker and antigen detection. Moreover, expanding applications in food safety, environmental testing, and drug discovery are further accelerating the global market share.

By type, the Optical Filter ELISA Analyzers segment holds the largest market share due to its cost-effectiveness, simplicity of operation, and suitability for routine diagnostic testing. Meanwhile, the Optical Grating ELISA Analyzers segment is projected to register the fastest market growth, supported by higher analytical sensitivity, broader wavelength range, and compatibility with advanced assays. The combination of precision optics and automation in these analyzers continues to enhance laboratory productivity and test reliability across various applications.

Based on application, the Hospital segment dominates the market share as ELISA remains a key diagnostic method for infectious diseases, autoimmune conditions, and allergy testing. The Biopharmaceutical Company segment is witnessing rapid market growth, fueled by increased R&D spending on biologics, vaccines, and clinical trial monitoring. In addition, Food Testing Companies and Universities and Research Institutes represent growing end users, leveraging ELISA analyzers for food safety screening, toxicology studies, and academic research on molecular interactions.

The market forecast indicates a positive outlook, with continuous technological innovation and automation driving sustained market growth. Integration of digital data management, miniaturized assay platforms, and AI-based analysis is expected to transform future diagnostic workflows. Expanding use of multiplexed ELISA systems, coupled with growing awareness of preventive healthcare and quality assurance in biomanufacturing, is set to further strengthen the Enzyme-linked Immunosorbent Assay (ELISA) Analyzers Market and its role in next-generation diagnostic and research solutions.

Segment by Type

• Optical Filter ELISA Analyzers
• Optical Grating ELISA Analyzers

Segment by Application

• Hospital
• Biopharmaceutical Company
• Food Testing Company
• Universities and Research Institutes
• Others

By Company

Thermo Fisher, PerkinElmer, Tecan, BioTek, EUROIMMUN, DiaSorin, BIO-RAD, Molecular Devices, Dynex Technologies, BMG Labtech, KHB, Promega, Trinity Biotech plc., Biochrom, Berthold, Awareness, Adaltis, Erba Mannheim, Dialab, STRATEC SE

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-0V7282/global-enzyme-linked-immunosorbent-assay-elisa-analyzers

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.